Needles Market, By Needles Type (Conventional Needless and Safety Needless), By Delivery Site (Intradermal, Subcutaneous, Intravenous, Intramuscular, and Intraperitoneal), By Application (Surgical Suture Needless, Pen Needless in Diabetes, Blood Collection Needless, Ophthalmic Procedure Needless, Dentistry Needless, Insufflation Needless, and Other Needless), By Material (Stainless Steel Needless, Plastic Needless, Glass Needless, and PEEK Needless), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In : Dec 2023

Code : CMI1331

Pages :240

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

North America North America is the dominant region in the global needle market over the past few decades. With the presence of leading medical device companies and well-established healthcare infrastructure, the US and Canada account for the largest share. Major players such as Abbott have established manufacturing and distribution networks across the globe. This helps them cater to the growing demand from other key markets. Besides domestic demand, North America also caters to the export markets. The region exports needles not only to developed countries but also emerging economies with growing healthcare needs. Strict regulations ensure product quality and safety. This has enhanced the brand image of North American players in international markets. The pricing of needles from the region is also competitive due to economies of scale. Overall, the North American needle market offers manufacturers an ideal mix of demand, supply, and regulatory environment to achieve dominance.

Asia Pacific region has emerged as the fastest growing market for needles in recent years. Countries like India, China, and Indonesia have a huge patient population and rising access to healthcare. This is driving the use of needles for therapeutic applications as well as vaccination programs across the region. At the same time, many Asian countries are also actively working to develop their domestic medical devices industry. This is attracting major investments from multinational market players looking to tap into the large market. They are setting up manufacturing units to cater to the local demand. The region is also aiming to reduce its dependence on imports for needles and related products. The favorable business environment in countries like India and China is a big attraction for setting up cost-competitive manufacturing bases. If this growth momentum continues, Asia Pacific will play a much bigger role in shaping the global needle market landscape in the near future.

In the Europe region, the needle type segment is dominated by conventional needles for subcutaneous and intramuscular injections. Conventional needles account for over 75% of the total needle market due to their low cost and widespread adoption in routine healthcare procedures. Several European countries still rely heavily on conventional disposable needles for delivering common vaccines and medications. For instance, in May 2021, public health authorities in Italy released data showing that, over 95% of vaccine doses from 2018-2020 were administered using conventional needles. This is primarily because conventional needles are inexpensive and can be produced at large volumes, thus making them the preferred option for cash-strapped public health systems.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East & Africa: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa